Clin Colon Rectal Surg 2002; 15(1): 055-062
DOI: 10.1055/s-2002-23568
Copyright © 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Adjuvant Therapy for Rectal Cancer

Clifford Y. Ko1, 2 , Michael J. Stamos1, 3 , Arthur Zimmerman4 , Henry C. Yang1, 5
  • 1Department of Surgery, UCLA School of Medicine, Los Angeles, CA
  • 2RAND Corporation, Santa Monica, CA
  • 3Section of Colon and Rectal Surgery, Harbor-UCLA Medical Center, Los Angeles, CA
  • 4Department of Radiation Oncology, Harbor-UCLA Medical Center, Los Angeles, CA
  • 5Department of Medicine, Harbor-UCLA Medical Center, Los Angeles, CA
Further Information

Publication History

Publication Date:
03 April 2002 (online)

ABSTRACT

In 1990, the National Institutes of Health consensus statement for the treatment of rectal cancer concluded that ``combined postoperative chemotherapy and radiation therapy improves local control and survival in stage II and III patients and is recommended.'' Following the publication of this consensus statement, the conventional treatment for rectal cancer was bowel resection followed by adjuvant radiation and chemotherapy. In the years that followed, however, several new findings have been published and a multitude of issues has arisen. This article will attempt to succinctly focus on the best current evidence in the literature. Where possible, we include only Level I evidence (i.e., evidence from randomized controlled trials [RCTs]). Since the role of adjuvant therapy for rectal cancer is continuing to be modified, the purpose of this article is to describe and interpret the most current literature.

REFERENCES

  • 1 NIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer.  JAMA . 1990;  264 1444-1450
  • 2 Corman M L. Carcinoma of the rectum. Colon and Rectal Surgery. Philadelphia: Lippincott-Raven 1998: 733-762
  • 3 Gordon P H. Malignant neoplasms of the rectum In: Gordon PH, Nivatvongs S, eds. Principles and the Practice of Surgery for the Colon, Rectum, and Anus. St. Louis: Quality Medical Publ Inc; 1999: 720-809
  • 4 Nogueras J. Adjuvant therapy for rectal cancer In: Beck D, Wexner S, eds. Fundamentals of Anorectal Surgery. London: WB Saunders; 1998: 368-381
  • 5 Stearns M, Deddish M, Quan S, Leaming R. Preoperative roentgen therapy for cancer of rectum and rectosigmoid.  Cancer . 1974;  37 2866-2874
  • 6 Roswit B, Higgins G J, Keehn R. Preoperative irradiation for carcinoma of the rectum and rectosigmoid colon: report of a national Veterans Administration randomized study.  Cancer . 1975;  35 1597-1602
  • 7 Rider W, Palmer J, Mahoney L, Robertson C. Preoperative irradiation in operable cancer of the rectum: report of the Toronto trial.  Can J Surg . 1977;  20 335-338
  • 8 Second Report of an MRC Working Party. The evaluation of low dose preoperative X-ray therapy in the management of operable rectal cancer: results of a randomly controlled trial.  Br J Surg . 1984;  71 21-25
  • 9 Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial [comments] [published erratum appears in N Engl J Med 1997;May 22;336(21):1539].  N Engl J Med . 1997;  336 980-987
  • 10 Camma C, Giunta M, Fiorica F, Pagliaro L, Craxi A, Cattone M. Preoperative radiotherapy for resectable rectal cancer: a meta-analysis.  JAMA . 2000;  284 1008-1015
  • 11 Cedermark B, Johansson H, Rutqvist L E, Wilking N. The Stockholm I trial of preoperative short-term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Colorectal Cancer Study Group.  Cancer . 1995;  75 2269-2275
  • 12 Goldberg P A, Nicholls R J, Porter N H, Love S, Grimsey J E. Long-term results of a randomised trial of short-course low-dose adjuvant preoperative radiotherapy for rectal cancer: reduction in local treatment failure [comments].  Eur J Cancer . 1994;  11 1602-1606
  • 13 Swedish Rectal Cancer Trial. Initial report from a Swedish multicentre study examining the role of preoperative irradiation in the treatment of patients with resectable rectal carcinoma. Swedish Rectal Cancer Trial.  Br J Surg . 1993;  80 1333-1336
  • 14 MRC Rectal Cancer Working Party. Randomised trial of surgery alone versus surgery followed by radiotherapy for mobile cancer of the rectum.  Lancet . 1996;  348 1610-1614
  • 15 Frykholm G J, Glimelius B, Pahlman L. Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects.  Dis Colon Rectum . 1993;  36 564-572
  • 16 Gastrointestinal Tumor Study Group. Prolongation of the disease-free interval in surgically treated rectal carcinoma.  N Engl J Med . 1985;  312 1465-472
  • 17 Douglass H, Moertel C G, Mayer R J. Survival after postoperative combination treatment of rectal cancer.  N Engl J Med . 1986;  315 1294-1295
  • 18 Thomas P, Lindblad A, and the GITSG. Adjuvant post-operative radiotherapy and chemotherapy in rectal carcinoma: a review of the Gastrointestinal Study Group experience.  Radiother Oncol . 1988;  13 245-252
  • 19 Fisher B, Wolmark N, Rockette H. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01.  J Natl Cancer Inst . 1988;  80 21-89
  • 20 Hafstrom L, Domellof L, Rudenstam C. Adjuvant chemotherapy with 5-fluorouracil, vincristine and CCNU for patients with Dukes' C colorectal cancer.  Br J Surg . 1990;  77 1345-1348
  • 21 Laurie J, Moertel C G, Fleming T. Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil: The North Central Cancer Treatment Group and the Mayo Clinic.  J Clin Oncol . 1989;  7 1447-1456
  • 22 Moertel C G, Fleming T, Macdonald J S. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.  N Engl J Med . 1990;  322 352-358
  • 23 Moertel C G, Fleming T, Macdonald J S. The intergroup study of 5-FU + levamisole and levamisole alone as adjuvant therapy for stage C colon cancer: a final report.  Proc Am Soc Clin Oncol [abstract] . 1992;  11 161
  • 24 Moertel C G, Fleming T, Macdonald J S. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report.  Ann Intern Med . 1995;  122 321-326
  • 25 Wolmark N, Rockette H, Mamounas E. Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from the National Surgical Adjuvant Breast and Bowel Project C-04.  J Clin Oncol . 1999;  17 3553-3559
  • 26 Haller D G, Catalano P, Macdonald J S. Fluorouracil, leucovorin, and levamisole adjuvant therapy for colon cancer: Five year final report of INT-0089 [abstract].  Proc Am Soc Clin Oncol . 1998;  17 256a
  • 27 Boulis-Wassis S, Gerard A, Loygue J. Final results of a randomized trial on the treatment of rectal cancer with preoperative radiotherapy alone or in combination with 5-fluorouracil followed by radical surgery: Trial of the European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative Group.  Cancer . 1984;  53 1811-1818
  • 28 Krook J E, Moertel C G, Gunderson L L. Effective surgical adjuvant therapy for high-risk rectal carcinoma [comments].  N Engl J Med . 1991;  324 709-715
  • 29 O'Connell M J, Martenson J A, Wieand H S. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery.  N Engl J Med . 1994;  331 502-507
  • 30 Wolmark N, Wieand H S, Hyams D M. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02 [comments].  J Natl Cancer Inst . 2000;  92 388-396
  • 31 Tveit K M, Guldvog I, Hagen S. Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes' B and C rectal cancer. Norwegian Adjuvant Rectal Cancer Project Group.  Br J Surg . 1997;  84 1130-1135
  • 32 Tepper J E, O'Connell M J, Petroni G R. Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of intergroup 0114.  J Clin Oncol . 1997;  15 2030-2039
  • 33 Roh M, Petrelli N, Wieand H S. Phase III randomized trial of preoperative versus postoperative multimodality therapy in patients with carcinoma of the rectum (NSABP R-03) [abstract].  Proc Am Soc Clin Oncol . 2001;  20 123a
  • 34 Heald R J, Moran B J, Ryall R D, Sexton R, MacFarlane J K. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997.  Arch Surg . 1998;  133 894-899
  • 35 Kapiteijn E, Marijnen C, Nagtegaal I. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.  N Engl J Med . 2001;  345 638-646
  • 36 Kligerman M. Preoperative radiation therapy in rectal cancer.  Cancer . 1975;  36 691-695
  • 37 Higgins G, Humphrey E, Dwight R. Preoperative radiation and surgery for cancer of the rectum: Veterans' Administration Surgical Oncology Group Trial II.  Cancer . 1986;  58 352-359
  • 38 Gerard J P, Buyse M, Nordlinger B. Preoperative radiotherapy as adjuvant treatment of rectal cancer.  Ann Surg . 1988;  308 606-612
  • 39 Reis Neto J, Guilici F, Reis Neto Jr J. A comparison of nonoperative vs preoperative radiotherapy in rectal carcinoma.  Dis Colon Rectum . 1989;  32 702-710
  • 40 Horn A, Morild I, Dahl O. Tumour shrinkage and downstaging after preoperative radiation of rectal adenocarcinomas.  Radiother Oncol . 1990;  18 19-28
  • 41 Stockholm Rectal Cancer Study Group. Preoperative short-term radiation therapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Rectal Cancer Study Group.  Cancer . 1990;  66 49-55
  • 42 Marsh P J, James R D, Schofield P F. Adjuvant preoperative radiotherapy for locally advanced rectal carcinoma. Results of a prospective, randomized trial.  Dis Colon Rectum . 1994;  37 1205-1214
  • 43 Stockholm Colorectal Cancer Study Group. Randomized study on preoperative radiotherapy in rectal carcinoma.  Ann Surg Oncol . 1996;  3 423-430
  • 44 Baslev I, Pedersen M, Teglbjaerg P S. Postoperative radiotherapy in Dukes' B and C carcinoma of the rectum and rectosigmoid. A randomized multicentre study.  Cancer . 1986;  58 22-28
  • 45 Treurniet-Donker A D, van Putten L W, Wereldsma J C. Postoperative radiation therapy for rectal cancer. An interim analysis of a prospective, randomized multicenter trial in The Netherlands [comments].  Cancer . 1991;  67 2042-2048
  • 46 Arnaud J P, Nordlinger B, Bosset J F. Radical surgery and postoperative radiotherapy as combined treatment in rectal cancer. Final results of a phase III study of the European Organization for Research and Treatment of Cancer.  Br J Surg . 1997;  84 352-357
  • 47 Rockette H, Deutsch M, Petrelli N. Effect of postoperative radiation therapy when used with adjuvant chemotherapy in Dukes' B and C rectal cancer: results from NSABP R-02 [abstract].  Proc Am Soc Clin Oncol . 1994;  13 193
  • 48 Merchant N B, Guillem J G, Paty P B. T3N0 rectal cancer: results following sharp mesorectal excision and no adjuvant therapy.  J Gastrointest Surg . 1999;  3 642-647
  • 49 Willett C G, Badizadegan K, Ancukiewicz M, Shellito P C. Prognostic factors in stage T3 N0 rectal cancer: do all patients require postoperative pelvic irradiation and chemotherapy?.  Dis Colon Rectum . 1999;  2 167-173